Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Psychopharmacology: rational and irrational polypharmacy.

Literature DB >> 11474046

Psychopharmacology: rational and irrational polypharmacy.

S J Kingsbury¹, D Yi, G M Simpson.

Abstract

Mesh：

Substances：
Antidepressive Agents

Year: 2001 PMID： 11474046 DOI： 10.1176/appi.ps.52.8.1033

Source DB: PubMed Journal: Psychiatr Serv ISSN： 1075-2730 Impact factor: 3.084

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

1. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network.

Authors: Deborah A Zarin; Julia L Young; Joyce C West
Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2005-01 Impact factor: 4.328

2. Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Authors: Cynthia A Fontanella; Lynn A Warner; Gary S Phillips; Jeffrey A Bridge; John V Campo
Journal: Psychiatr Serv Date: 2014-10-31 Impact factor: 3.084

3. Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.

Authors: Lone Baandrup; Jan Sørensen; Henrik Lublin; Merete Nordentoft; Birte Glenthoj
Journal: Eur J Health Econ Date: 2011-03-31

Review 4. Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

Authors: Maire O'Dwyer; Philip McCallion; Mary McCarron; Martin Henman
Journal: Ther Adv Drug Saf Date: 2018-06-20

Psychopharmacology: rational and irrational polypharmacy.

1. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network.

2. Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

3. Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.

Review 4. Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

5. Antipsychotic Use Pattern in People with Psychotic Disorder Living in Board and Care Facilities.

6. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Review 7. Antipsychotic polypharmacy in schizophrenia: benefits and risks.

8. Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey.

9. Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.

10. Disparities in identification of comorbid diagnoses in children with ADHD.